Whether products high-quality difficulties contributed directly to the closure final decision isn't confirmed. But the screening history adds a vital dimension to the Peptide Sciences story: the corporate’s reputation for dependability was not uniform throughout its comprehensive catalog, especially for newer plus much more complex compounds.